Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Titel:
Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer
Auteur:
Lim, Emerson A. Schweizer, Michael T. Chi, Kim N. Aggarwal, Rahul Agarwal, Neeraj Gulley, James Attiyeh, Edward Greger, James Wu, Shujian Jaiprasart, Pharavee Loffredo, John Bandyopadhyay, Nibedita Xie, Hong Hansen, Aaron R.